We dare for more in every aspect of what we do – advancing our portfolio of precision therapies for central nervous system disorders – to make the impossible possible.
The field of neurology has been primed for a revolution in how new therapies are discovered. We have taken the charge to develop them.
We come to work every single day with a drive to create lasting impact for humans in need.
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance.
Praxis is the process of using a theory or learning in a practical way. It is the mindset that allows us to simplify the complex and independently define a solution without being restricted by predefined processes.
Our Expanded Access Policy
Each of our programs is based on four key principles that we believe will both increase the probability of success and allow us to efficiently translate insights into high-impact therapies:
Current Developmental Pipeline
Developing Treatments Inspired by the Genetics of Epilepsy
Enabled by Two Platforms
Targeting movement disorders & epilepsies connected by neuronal imbalance
We have attracted a talented team of scientists and researchers in genetics and biology, chemistry and translational medicine as well as business leaders with established track records of successfully executing innovative drug discovery and development programs.
Our mission is to help patients by delivering life-altering treatments faster and more effectively than has ever been done before. Agnostic to the source of an idea, we work together to find the most practical solutions for patients as quickly and efficiently as possible. We need talented and motivated individuals to make this happen.
We share a common vision of reshaping the human condition into a more freeing and fulfilled existence by developing high impact medicines for patients and families affected by and living with complex brain disorders.